* SFDA key advisory panel members and external subject matter expert reviewers for
CTA/IND, NDA/PMA applications
* Full partnership with an ARO (Academic Research Organization)
affiliated with the National Center for Cardiovascular Diseases
* Completion of more than 100 drug and medical device clinical
trials in multiple therapeutic areas including Cardiovascular,
Oncology, and CNS.
* 19 clinical studies currently ongoing
* More than 20 SFDA submissions under review
* Authorship of more than 10 SFDA statistical guidelines
Faster Development
Through Emerging Markets
Copyright 2012 Truevic